Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Invasive candidiasis

Invasive candidiasis

Part of Fungal infection

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Invasive candidiasis

12 trials tracked for Invasive candidiasis: 7 in phase 3 or 4 and 1 with published results. The most-cited published study has 178 citations.

12Trials tracked
7Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 5 Phase 2 3 Other / NA 2
  1. Phase 3 Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Completed · 178 cited
  2. Phase 4 This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis Completed
  3. Phase 4 Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Completed
  4. Phase 3 Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) Completed
  5. Phase 3 Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment Completed
  6. Phase 3 A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) Completed
Show 6 more trials
  1. Phase 3 Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study Completed
  2. Phase 2 Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis Completed
  3. Phase 2 A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) Completed
  4. Phase 2 CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension Completed
  5. N/A Invasive Candidiasis in Saudi ICUs Completed
  6. N/A β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Secondary analysis of 342 sepsis patients reveals limited diagnostic utility for serum biomarkers in invasive candidiasis diagnosis
Emergency Medicine RCT
Secondary analysis of 342 sepsis patients reveals limited diagnostic utility for serum biomarkers in invasive candidiasis diagnosis Doctors tested blood markers to find infection signs in sick patients quickly
Analysis of 342 sepsis patients across German ICUs shows serum antigens rise in infection, but antibodies do not. Single biomarkers offer mo…
A study of 342 sick patients found that one specific blood test works best for spotting dangerous infections. Combining multiple tests did n…
May 13, 2026
Pooled analysis review of rezafungin versus caspofungin for candidemia and invasive candidiasis
Drug Pipeline
Pooled analysis review of rezafungin versus caspofungin for candidemia and invasive candidiasis Weekly Drug Clears Blood Fungus Faster Than Daily Treatment
This review synthesizes a pooled analysis of two randomized trials evaluating rezafungin versus caspofungin in adults with candidemia or inv…
A new weekly medication clears blood infections just as well as daily shots, offering hope for shorter care.
Apr 19, 2026

Research across Fungal infection

Related studies from across the Fungal infection family.

Review of antifungal options for vulvovaginal candidiasis in women of reproductive age
Infectious Disease Sys. Review
Review of antifungal options for vulvovaginal candidiasis in women of reproductive age New Treatments for a Common Yeast Infection That Keeps Coming Back
This review examines antifungal treatments for vulvovaginal candidiasis in women of reproductive age. The authors discuss azoles, boric acid…
If you have a yeast infection that won't go away with standard creams, new oral medications and even boric acid are changing how doctors tre…
Frontiers May 15, 2026